Globus Medical, Inc. Earnings

Globus Medical, Inc.’s revenue fell -1.41% since last year same period to $598.12Mn in the Q1 2025. On a quarterly growth basis, Globus Medical, Inc. has generated -9% fall in its revenue since last 3-months.

Globus Medical, Inc.’s net profit jumped 1160.31% since last year same period to $75.46Mn in the Q1 2025. On a quarterly growth basis, Globus Medical, Inc. has generated 184.71% jump in its net profits since last 3-months.

Globus Medical, Inc.’s net profit margin jumped 1175.45% since last year same period to 12.62% in the Q1 2025. On a quarterly growth basis, Globus Medical, Inc. has generated 212.87% jump in its net profit margins since last 3-months.

Globus Medical, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 43.19.

Globus Medical, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.57 - a -23.86% fall from last quarter’s estimates.

Globus Medical, Inc.’s earning per share (EPS) estimates for the current year stand at 0.57.

Globus Medical, Inc.’s earning per share (EPS) fell -5.56% since last year same period to 0.68 in the Q1 2025. This indicates that the Globus Medical, Inc. has generated -5.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Globus Medical, Inc.’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Globus Medical, Inc.’s return on equity (ROE) stands at 0.05.